Design of dantrolene-derived probes for radioisotope-free photoaffinity labeling of proteins involved in the physiological Ca2+ release from sarcoplasmic reticulum of skeletal muscle

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 5, 2005, Pages 1289-1294

  Hosoya, Takamitsu ^a   Hiramatsu, Toshiyuki ^a   Ikemoto, Takaaki ^a   Aoyama, Hiroshi ^a   Ohmae, Tatsuro ^a   Endo, Makoto ^b   Suzuki, Masaaki ^a  

^a GIFU UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLENE; AZIDE; CALCIUM ION; DANTROLENE; GIF 0430; GIF 0665; MARKER; PROTEIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CROSS LINKING; FLUORESCENCE; INHIBITION KINETICS; MOLECULAR MECHANICS; MOLECULAR PROBE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PHOTOAFFINITY LABELING; PROTEIN TARGETING; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SYNTHESIS;

EID: 13944276317     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.01.041     Document Type: Article

References (67)

1. H.R. Snyder Jr., C.S. Davis, R.K. Bickerton, and R.P. Halliday J. Med. Chem. 10 1967 807
2. Davis, C. S.; Snyder, H. R., Jr. U.S. Patent 3,415,821, 1968
3. A. Ward, M.O. Chaffman, and E.M. Sorkin Drugs 32 1986 130
4. T. Krause, M.U. Gerbershagen, M. Fiege, R. Weißhorn, and F. Wappler Anaesthesia 59 2004 364
5. G.G. Harrison Br. J. Anaesth. 47 1975 62
6. M.E. Kolb, M.L. Horne, and R. Martz Anesthesiology 56 1982 254
7. M. Endo, S. Yagi, T. Ishizuka, K. Horiuti, Y. Koga, and K. Amaha Biomed. Res. 4 1983 83
8. D.H. MacLennan, and M.S. Phillips Science 256 1992 789
9. C.F. Louis, E.M. Balog, and B.R. Fruen Biosci. Rep. 21 2001 155
10. M. Endo R.M. Simmons Muscular Contraction 1992 Cambridge University Press New York 67 82
11. T. Ohta, and M. Endo Proc. Jpn. Acad. 62 1986 76
12. K.O. Ellis, and S.H. Bryant Naunyn-Schmiedeberg's Arch. Pharmacol. 274 1972 107
13. K.O. Ellis, and J.F. Carpenter Naunyn-Schmiedeberg's Arch. Pharmacol. 275 1972 83
14. T. Ikemoto, and M. Endo M. Endo Y. Kurachi M. Mishina Pharmacology of Ionic Channel Function. Activators and Inhibitors 2000 Springer Berlin 583 603
15. R.M. Simmons Muscular Contraction 1992 Cambridge University Press New York
16. M. Endo Curr. Top. Membr. Transp. 25 1985 181
17. M.F. Schneider Annu. Rev. Physiol. 56 1994 463
18. E. Ríos, and G. Pizarro Physiol. Rev. 71 1991 849
19. R. Sitsapesan A.J. Williams The Structure and Function of Ryanodine Receptors 1998 Imperial College London
20. M. Iino Jpn. J. Physiol. 49 1999 325
21. M. Kasai, T. Kawasaki, and N. Yamaguchi Biophys. Chem. 82 1999 173 and references cited therein
22. T. Ohta, and M. Endo Proc. Jpn. Acad. 62 1986 329
23. T. Ohta, M. Endo, T. Nakano, Y. Morohoshi, K. Wanikawa, and A. Ohga Am. J. Physiol. 256 1989 C358
24. T. Ikemoto, T. Hosoya, H. Aoyama, Y. Kihara, M. Suzuki, and M. Endo Br. J. Pharmacol. 134 2001 729
25. T. Hosoya, H. Aoyama, T. Ikemoto, T. Hiramatsu, Y. Kihara, M. Endo, and M. Suzuki Bioorg. Med. Chem. Lett. 12 2002 3263
26. T. Hosoya, H. Aoyama, T. Ikemoto, Y. Kihara, T. Hiramatsu, M. Endo, and M. Suzuki Bioorg. Med. Chem. 11 2003 663
27. A. Singh, E.R. Thornton, and F.H. Westheimer J. Biol. Chem. 237 1962 3006
28. J. Brunner Annu. Rev. Biochem. 62 1993 483
29. F. Kotzyba-Hibert, I. Kapfer, and M. Goeldner Angew. Chem., Int. Ed. Engl. 34 1995 1296
30. S.A. Fleming Tetrahedron 51 1995 12479
31. Y. Hatanaka, H. Nakayama, and Y. Kanaoka Rev. Heteroatom Chem. 14 1996 213
32. G. Dormán Bioorganic Chemistry of Biological Signal Transduction H. Waldmann Topics in Current Chemistry 211 2001 Springer Berlin 169 225
33. G. Dormán, and G.D. Prestwich Trends Biotechnol. 18 2000 64
34. Y. Hatanaka, and Y. Sadakane Curr. Top. Med. Chem. 2 2002 271
35. Parness et al. reported the synthesis of tritium labeled azido congener of 1 and proposed that it binds to RyR1 S.S. Palnitkar, B. Bin, L.S. Jimenez, H. Morimoto, P.G. Williams, K. Paul-Pletzer, and J. Parness J. Med. Chem. 42 1999 1872
36. K. Paul-Pletzer, S.S. Palnitkar, L.S. Jimenez, H. Morimoto, and J. Parness Biochemistry 40 2001 531
37. K. Paul-Pletzer, T. Yamamoto, M.B. Bhat, J. Ma, N. Ikemoto, L.S. Jimenez, H. Morimoto, P.G. Williams, and J. Parness J. Biol. Chem. 277 2002 34918
38. Unpublished results
39. T. Hosoya, T. Hiramatsu, T. Ikemoto, M. Nakanishi, H. Aoyama, A. Hosoya, T. Iwata, K. Maruyama, M. Endo, and M. Suzuki Org. Biomol. Chem. 2 2004 637
40. E. Saxon, and C.R. Bertozzi Science 287 2000 2007
41. K.L. Kiick, E. Saxon, D.A. Tirrell, and C.R. Bertozzi Proc. Natl. Acad. Sci. U.S.A. 99 2002 19
42. J.A. Prescher, D.H. Dube, and C.R. Bertozzi Nature 430 2004 873
43. M. Köhn, and R. Breinbauer Angew. Chem., Int. Ed. 43 2004 3106
44. P.F. van Swieten, M.A. Leeuwenburgh, B.M. Kessler, and H.S. Overkleeft Org. Biomol. Chem. 3 2005 20 and references cited therein
45. V.V. Rostovtsev, L.G. Green, V.V. Fokin, and K.B. Sharpless Angew. Chem., Int. Ed. 41 2002 2596
46. C.W. Tornøe, C. Christensen, and M. Meldal J. Org. Chem. 67 2002 3057
47. R. Breinbauer, and M. Köhn ChemBioChem 4 2003 1147
48. H.C. Kolb, and K.B. Sharpless Drug Discov. Today 8 2003 1128 and references cited therein
49. For photoaffinity biotinylation, see F.M. Finn, C.J. Stehle, and K. Hofmann Biochemistry 24 1985 1960
50. Y. Hatanaka, M. Hashimoto, and Y. Kanaoka Bioorg. Med. Chem. 2 1994 1367
51. K. Fang, M. Hashimoto, S. Jockusch, N.J. Turro, and K. Nakanishi J. Am. Chem. Soc. 120 1998 8543
52. M. Hashimoto, S. Okamoto, K. Nabeta, and Y. Hatanaka Bioorg. Med. Chem. Lett. 14 2004 2447 and references cited therein
53. See also Ref. 10. For post-PAL modification (PPALM), see E. Nakata, T. Nagase, S. Shinkai, and I. Hamachi J. Am. Chem. Soc. 126 2004 490 and references cited therein
54. H.C. Kolb, M.G. Finn, and K.B. Sharpless Angew. Chem., Int. Ed. 40 2001 2004
55. H. Tomioka, and S. Sawai Org. Biomol. Chem. 1 2003 4441
56. 3OD adduct 14 (δ -0.5 ppm) and a linear diazoisomer of 11 (δ 18.7 ppm) in ca. 2:1 ratio. Due to its UV absorption character, the latter was smoothly converted to 14 by exposure to UV at a wavelength of 302 nm for 10 min. See J. Brunner, H. Senn, and F.M. Richards J. Biol. Chem. 255 1980 3313
57. M. Nassal Liebigs Ann. Chem. 1983 1510 See also Ref. 13
58. T.R. Chan, R. Hilgraf, K.B. Sharpless, and V.V. Fokin Org. Lett. 6 2004 2853
59. The compound 14 was able to isolate in 63% yield
60. +
61. K. Sonogashira, Y. Tohda, and N. Hagihara Tetrahedron Lett. 1975 4467
62. S. Urgaonkar, and J.G. Verkade J. Org. Chem. 69 2004 5752
63. T. Ikemoto, and M. Endo Br. J. Pharmacol. 134 2001 719
64. TC fraction was isolated from back and leg muscles from Japanese white rabbit (2-2.5 kg, male) by sucrose density gradient centrifugation according to the reported protocol A. Saito, S. Seiler, A. Chu, and S. Fleischer J. Cell Biol. 99 1984 875
65. GIF-0162 (32) is a selective inhibitor for PCR without an azido function. Normalized values on twitch contraction and CICR rate of 32 (50 μM) were 36.3 ± 10.2% (n = 3) and 90.5 ± 4.2% (n = 4), respectively
66. 125I]-2. The detailed analyses to compare them are in progress
67. We prepared the phenyl ring-modified azido congener of 1 and found that it strongly inhibits not only the PCR but also the CICR, as is the case with 1 (unpublished data). This implicates that such an azido congener is functionally different from the derivatives described in the present study